Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Avantor Inc Market Cap
Based on ratings from 0 stock analysts, the Avantor Inc stock price is expected to increase by 12.08% in 12 months. This is calculated by using the average 12-month stock price forecast for Avantor Inc. The lowest target is $20 and the highest is $34. Please note analyst price targets are not guaranteed and could be missed completely.
AVTR is a stock in Healthcare which has been forecasted to be worth $27.74 as an average. On the higher end, the forecast price is $34 USD by from Raymond James and on the lower end AVTR is forecasted to be $20 by Daniel Brennan from UBS.
These are the latest 20 analyst ratings of AVTR.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Daniel Brennan UBS | Buy | $29 | Maintains | Oct 8, 2024 |
| Conor McNamara RBC Capital | Outperform | $34 | Reiterates | Sep 26, 2024 |
| Brandon Couillard Wells Fargo | Overweight | $30 | Initiates | Aug 27, 2024 |
| Tejas Savant Morgan Stanley | Overweight | $29 | Maintains | Jul 29, 2024 |
| Daniel Arias Stifel | Buy | $28 | Maintains | Jul 29, 2024 |
| Luke Sergott Barclays | Overweight | $28 | Maintains | Jul 29, 2024 |
| Dan Brennan TD Cowen | Buy | $31 | Maintains | Jul 29, 2024 |
| Conor McNamara RBC Capital | Outperform | $31 | Reiterates | Jul 29, 2024 |
| Catherine Schulte Baird | Outperform | $27 | Maintains | Jul 29, 2024 |
| Conor McNamara RBC Capital | Outperform | $31 | Maintains | Jul 15, 2024 |
| Patrick Donnelly Citigroup | Neutral | $23 | Downgrade | Jul 10, 2024 |
| Vijay Kumar Evercore ISI Group | Outperform | $27 | Maintains | Jul 2, 2024 |
| Luke Sergott Barclays | Overweight | $25 | Maintains | Jun 28, 2024 |
| Catherine Schulte Baird | Outperform | $26 | Maintains | Apr 29, 2024 |
| Justin Bowers Deutsche Bank | Hold | $25 | Maintains | Apr 18, 2024 |
| Luke Sergott Barclays | Overweight | $30 | Maintains | Apr 10, 2024 |
| Vijay Kumar Evercore ISI Group | Outperform | $28 | Maintains | Apr 4, 2024 |
| Catherine Schulte Baird | Outperform | $26 | Maintains | Feb 15, 2024 |
| Luke Sergott Barclays | Overweight | $27 | Maintains | Feb 15, 2024 |
| Patrick Donnelly Citigroup | Buy | $30 | Maintains | Feb 15, 2024 |
When did it IPO
2019
Staff Count
14,500
Country
United States
Sector/Industry
Healthcare/Medical Instruments & Supplies
CEO
Mr. Michael Stubblefield
Market Cap
$16.64B
In 2023, AVTR generated $6.97B in revenue, which was a decrease of -7.26% from the previous year. This can be seen as a signal that AVTR's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 02 Oct 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Investors in the Medical Services sector may find Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR) appealing options for potential value.
Why It Matters - The comparison between Pediatrix Medical Group and Avantor highlights potential investment opportunities in the Medical Services sector, prompting analysis of their value for informed decision-making.
Mon, 30 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Avantor, Inc. (NYSE: AVTR) announced that its NuSil brand received the 2024 North American Daily Kaizen Management award, recognizing its commitment to enhancing customer experience.
Why It Matters - Avantor's recognition for its commitment to continuous improvement may enhance operational efficiency and customer satisfaction, potentially boosting long-term profitability and investor confidence.
Fri, 27 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Avantor, Inc. (NYSE: AVTR) will release its Q3 2024 financial results on October 25 before market open and host a conference call at 8:00 a.m. on the same day.
Why It Matters - Avantor's upcoming Q3 2024 financial results and conference call could significantly impact its stock performance, influencing investor sentiment and market perceptions.
Wed, 25 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Avantor, Inc. has signed a 10-year virtual power purchase agreement to provide 25GWh of renewable energy annually starting in 2026, enhancing its commitment to renewable energy and solar installations.
Why It Matters - Avantor's commitment to renewable energy through a long-term purchase agreement enhances its sustainability profile, potentially attracting eco-conscious investors and reducing future energy costs.
Mon, 23 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Avantor, Inc. (NYSE: AVTR) will present and exhibit at BioProcess International 2024 in Boston from September 23-26, highlighting its role in life sciences and advanced technology.
Why It Matters - Avantor's participation in BioProcess International 2024 highlights its commitment to innovation and leadership in the life sciences sector, potentially enhancing its market position and investor confidence.
Fri, 13 Sep 2024
Sentiment - POSITIVE
Source - Seeking Alpha
Summary - Top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—made up 50% of the equity portfolio, with Avantor up 26% in July and Baxter showing strong post-earnings growth.
Why It Matters - The strong performance of Avantor and Baxter, along with their positive earnings and growth potential, indicates robust recovery trends that could enhance overall portfolio value.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
